UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology

Magnetic resonance in medicine, 2022-07, Vol.88 (1), p.365-379

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

European urology, 2021-06, Vol.79 (6), p.762-771

2021

Link zum Volltext

Verfügbarkeit prüfen

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer

PloS one, 2015-05, Vol.10 (5), p.e0125576-e0125576

2015

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells

Cell reports (Cambridge), 2018-04, Vol.23 (1), p.58-67

2018

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status

BMC cancer, 2017-05, Vol.17 (1), p.367-367, Article 367

2017

Link zum Volltext

Verfügbarkeit prüfen

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy

BMC cancer, 2015-09, Vol.15 (1), p.633-633, Article 633

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis

Nature cell biology, 2019-11, Vol.21 (11), p.1403

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1097: The Phlpp2 phosphatase protects Myc and is a target for the prevention of prostate cancer metastasis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1097-1097

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy

The Journal of urology, 2014-07, Vol.192 (1), p.252-259

2014

Link zum Volltext

Verfügbarkeit prüfen

Genomic evolution from hormonal therapies and suitability of prostate cancer diagnostic specimens for metastatic prostate cancer (mPC) genomic stratification

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.143-143

2022

Link zum Volltext

Verfügbarkeit prüfen

The PHLPP2 phosphatase is a druggable driver of prostate cancer progression

The Journal of cell biology, 2019-06, Vol.218 (6), p.1943-1957

2019

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naïve prostate cancer (mHNPC): ZZFIRST

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.TPS209-TPS209

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer

European journal of cancer (1990), 2014-11, Vol.50 (17), p.2994-3002

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2863: TMPRSS2-ERG influences IGF-1R expression and affects its prognostic value in prostate cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2863-2863

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2304: Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomic and transcriptomic evolution

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2304-2304

2023

Link zum Volltext

Verfügbarkeit prüfen

Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies

JCO precision oncology, 2022-07, Vol.6, p.e2200195

2022

Link zum Volltext

Verfügbarkeit prüfen

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents

Oncotarget, 2015-06, Vol.6 (18), p.16611-16622

2015

Link zum Volltext

Verfügbarkeit prüfen

miRNAs as biomarkers in prostate cancer

Clinical & translational oncology, 2012-11, Vol.14 (11), p.803-811

2012

Link zum Volltext

Verfügbarkeit prüfen

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer: e0125576

PloS one, 2015-05, Vol.10 (5)

2015

Link zum Volltext

Verfügbarkeit prüfen

New biomarkers to optimize the selection and follow up of patients with prostate cancer on active surveillance

Archivos españoles de urología, 2014-06, Vol.67 (5), p.462

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(14)
Humans
(13)
Male
(13)
Prostate Cancer
(10)
Prostatic Neoplasms - Genetics
(9)
Prostatic Neoplasms - Diagnosis
(7)
Oncology
(6)
Animals
(5)
Tumors
(5)
Aged
(4)
Biomarkers, Tumor - Genetics
(4)
Cell Biology
(4)
Cell Line, Tumor
(4)
Disease Progression
(4)
Mice
(4)
Prognosis
(4)
Prostatic Neoplasms - Pathology
(4)
Urology & Nephrology
(4)
Gene Expression Regulation, Neoplastic
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer

Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy

Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors

Abstract 1097: The Phlpp2 phosphatase protects Myc and is a target for the prevention of prostate cancer metastasis

Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy

Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial

Genomic evolution from hormonal therapies and suitability of prostate cancer diagnostic specimens for metastatic prostate cancer (mPC) genomic stratification

The PHLPP2 phosphatase is a druggable driver of prostate cancer progression

A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naïve prostate cancer (mHNPC): ZZFIRST

Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer

Abstract 2863: TMPRSS2-ERG influences IGF-1R expression and affects its prognostic value in prostate cancer

Abstract 2304: Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomic and transcriptomic evolution

Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents

miRNAs as biomarkers in prostate cancer

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer: e0125576

New biomarkers to optimize the selection and follow up of patients with prostate cancer on active surveillance

Suchergebnisse filtern